CSL 177.00 +1.89 +1.08% Volume: 316,890 April 19, 2021 4:00 PM ET View more


CIT’s Medical Technologies unit designs, develops and manufactures custom interconnect assemblies for thousands of life enhancing medical devices.

Our Approach

Mergers and acquisitions have been a driving force behind Carlisle’s sustained growth over our history, including over 80 acquisitions in the past 30 years. In the past decade alone, we have deployed over $4 billion and contemplate deploying a further $3 billion under Vision 2025. We seek synergistic acquisitions in core or adjacent markets. Characteristics of our investments include: highly specialized and highly engineered manufactured products; high performance, mission critical products designed to operate in harsh environments; and strong brands with leading market positions. Our current focus is to build out our Building Envelope platform within CCM and high other returning businesses.